Steris PLC | Income Statement

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,622
1,850
2,239
2,613
2,620
Cost of Goods Sold (COGS) incl. D&A
964
1,076
1,317
1,588
1,524
Gross Income
658
774
922
1,025
1,096
SG&A Expense
427
537
594
707
659
EBIT
231
237
328
318
435
Unusual Expense
23
10
115
90
17
Non Operating Income/Expense
-
-
1
1
14
Interest Expense
19
19
43
45
51
Pretax Income
188
209
172
185
355
Income Tax
59
74
60
74
63
Consolidated Net Income
129
135
112
111
292
Net Income
129
135
111
110
291
Net Income After Extraordinaries
129
135
111
110
291
Net Income Available to Common
129
135
111
110
291
EPS (Basic)
2.17
2.25
1.56
1.28
3.39
Basic Shares Outstanding
59
59
71
85
85
EPS (Diluted)
2.17
2.25
1.56
1.28
3.39
Diluted Shares Outstanding
60
60
71
86
86
EBITDA
306
329
471
506
614
Other Operating Expense
-
-
-
-
2
Non-Operating Interest Income
-
1
1
1
2
Minority Interest Expense
-
-
1
1
1

About Steris

View Profile
Address
Rutherford House
Chaddesden Derby DE21 6LY
United Kingdom
Employees -
Website http://www.steris.com
Updated 07/08/2019
STERIS Plc engages in the provision of infection prevention and other procedural products and services. It operates through the following segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers worldwide, including capital equipment, and related maintenance and installation services, as well as consumables.